IMARC Group, a leading market research company, has recently releases report titled “Anti-infectives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global anti-infectives market trends, growth, share, size, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Industry Overview of Anti-infectives Market

Anti-infectives, also known as antimicrobial agents or antibiotics, are a class of medications used to treat infections caused by harmful microorganisms, such as viruses, bacteria, fungi, and parasites. They comprise antibiotics, antivirals, and antifungals which are utilized to treat fungal infections and can target various components of fungal cells, such as cell membranes or enzymes necessary for growth. They also consist of antiparasitic, which are used to treat infections caused by parasites and can target numerous stages of the life cycle of parasites or disrupt their metabolic processes. They work by targeting specific components or processes within the microorganisms, hindering their growth, replication, or ability to cause harm. Anti-infectives are essential for controlling and treating infectious diseases, preventing their spread, and reducing associated morbidity and mortality. They reduce the risk of death from infection that would otherwise be lethal and control the spread of infectious diseases within communities, contributing to better public health outcomes. They are essential for preventing postoperative infections in cancer patients and diseases caused after organ transplantation. They are used to combat a wide range of infections that can cause harm to different parts of the body, including the skin, respiratory tract, urinary tract, gastrointestinal tract, and more.

How Big Is the Anti-infectives Market?

The global anti-infectives market size reached US$ 130.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 157.6 Billion by 2028, exhibiting a growth rate (CAGR) of 3.46% during 2023-2028.

Global Ultrasound Devices Market Trends and Drivers:

At present, the increasing demand for anti-infectives as they help alleviate symptoms, prevent complications, improve the overall health of individuals suffering from infectious diseases, and possess the ability to selectively target harmful microorganisms while minimizing damage to the cells of the host represents one of the crucial factors impelling the growth of the market. Besides this, the rising occurrence of various infectious diseases, along with the increasing emergence of novel viruses causing infectious ailments in individuals, is propelling the growth of the market. In addition, the growing research in developing various novel antimicrobial agents to overcome antimicrobial resistance and overuse of antimicrobials is offering a favorable market outlook. Apart from this, increasing technological advancements in diagnostics, therapeutics, and vaccine development, enabling targeted interventions and personalized treatment regimens, are supporting the growth of the market. Additionally, the rising convergence of computational biology, artificial intelligence (AI), and high-throughput screening methodologies to expedite drug discovery and optimization processes is propelling the growth of the market. Moreover, increasing investments in improving healthcare facilities and providing quality treatment to patients around the world are contributing to the growth of the market. Furthermore, the rising awareness about the proper usage and the importance of antimicrobials or anti-infectives among the masses is bolstering the market growth.

Report Segmentation:

The report has been segmented the market into following categories:

Breakup by Type:

• Antibacterial
• Antifungal
• Antiviral

Breakup by Route of Administration:

• Topical
• Oral
• Intravenous (IV)
• Others

Breakup by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Speciality Pharmacies
• Online Stores
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

List of Major Key Players:

Abbott Laboratories, Cipla Health Ltd. (Cipla Limited), F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Johnson & Johnson, Lupin Limited, Sandoz AG (Novartis AG) and Sun Pharmaceutical Industries Limited.